Stock fact sheet · data as of
Henry Schein, Inc. (HSIC): fair value, margin of safety and Wheel Score
Healthcare · Medical - Distribution · United States · Blend
Is HSIC undervalued?
HSIC closed at 86.99 on 16 Oct 2026, more than 30% above the GLS average fair value of 63.41. Only 3 of the 8 models that produced a value sit above the price. By our models the shares are priced well beyond what the filed earnings, cash flow and book value support; the Sunday Scan drops names like this at the "below fair value" rule.
There is a wide gap between GLS Growth (11.15) and 10 Cap (125.55). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.
The nightly engine files HSIC under Blend.
Nine valuation models for HSIC
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | 63.50 | -27% | Present value of the projected free cash flows, discounted at the cost of capital |
| Graham Number | 47.16 | -46% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 95.02 | +9% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 33.50 | -61% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 11.15 | -87% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 125.55 | +44% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 91.91 | +6% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | 39.47 | -55% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | -17.56 | -120% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 92.30 | +6% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Henry Schein, Inc. scores 6 of 9 on the Piotroski F-score: a middling result that passes the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. A GLS Moat score of 4.7/10 is a weak reading: the ten-year history the score grades (revenue, EPS, book value, margins, cash flow, share count, ROIC) has not been steady, so the Moat part of the Wheel Score contributes little.
Returns on capital are moderate - ROIC 5.7%, ROE 12.3%, ROA 3.5% - with debt at 1.14 times equity and a free-cash-flow yield of 5.6%.
Henry Schein, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Healthcare Distribution 93%, Technology 7% (quarter Q3 FY2024).
Institutional ownership scores 10/10, insider activity 1/10 and Congressional trading 1/10 on the GLS smart-money scales.
| Piotroski F-score | 6 / 9 | ROIC | 5.7% |
|---|---|---|---|
| GLS Moat | 4.7 / 10 | ROE | 12.3% |
| Debt / equity | 1.14 | ROA | 3.5% |
| Free-cash-flow yield | 5.6% | Payout ratio | 0% |
| Institutions | 10 / 10 | Insiders · Congress | 1 · 1 / 10 |
Wheel Score 56: Fair
A Wheel Score of 56 puts Henry Schein, Inc. in the Fair band - below the 70 the Sunday Scan requires. Value 0/25, Health 13/20, Moat 7/15, Premium 17/20 and Stability 18/20; the weakest part is Value (0/25).
Implied volatility is 32% on the near-the-money contracts 20-60 days out: some premium, but under the 35-60% range the Wheel Score pays full marks for (17 of 20 points). Chain open interest is 11,198 contracts across all expiries - enough for the wheel at normal size.
Volume runs at 963k shares a day on a market cap of $9.7B, with a beta of 0.84; the Stability part of the Wheel Score gives that 18 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 0 / 25 | -37% margin of safety | |
| Health | 13 / 20 | Piotroski 6/9 | |
| Moat | 7 / 15 | moat 4.7/10 | |
| Premium | 17 / 20 | implied volatility 32% | |
| Stability | 18 / 20 | 963k shares/day, $9.7B cap, beta 0.84 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
The next earnings report is due on 3 Nov 2026 (before the open), 18 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Distribution
The 12 companies below are the closest to Henry Schein, Inc. by market cap within the Medical - Distribution industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| CAH Cardinal Health, Inc. | 253.71 | 343.24 | +26% | 88Prime | $58.7B |
| COR Cencora, Inc. | 341.41 | 400.52 | +15% | 82Prime | $65.2B |
| AHG Akso Health Group | 1.35 | - | - | 29No options | $1.2B |
| MCK McKesson Corporation | 998.64 | 833.66 | -20% | 65Good | $116.4B |
| YI 111, Inc. | 3.11 | - | - | 26No options | $27M |
| ACH Accendra Health, Inc. | 0.2615 | - | - | 36Weak | $20M |
| EXHI Exlites Holdings International, Inc. | 0.4500 | - | - | 26No options | $20M |
| MEDS DataMEDS AI, Inc. | 2.85 | - | - | 24No options | $7M |
| AIXN AiXin Life International, Inc. | 0.2600 | - | - | 27No options | $6M |
| PDRX PD-Rx Pharmaceuticals, Inc. | 3.10 | 6.80 | +54% | 29No options | $5M |
| HKPD Cellyan Biotechnology Co., Ltd | 0.1099 | 0.3564 | +69% | 39No options | $5M |
| RDGT Ridgetech, Inc. | 0.8402 | 312.83 | +100% | 39No options | $755K |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about HSIC
Is HSIC undervalued right now?
No: at 86.99 the stock trades 37% above the GLS average fair value of 63.41 (data as of 16 Oct 2026), well beyond what trailing earnings, cash flow and book value support.
What is the Wheel Score of HSIC and what does it mean?
HSIC scores 56 out of 100 (Fair). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.
What is the GLS fair value for HSIC?
63.41 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Henry Schein, Inc. report earnings next?
The next earnings report is due on 3 Nov 2026 (before the open), 18 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.
Does HSIC have listed options, and how liquid are they?
Yes. The nightly snapshot found 178 listed contracts with 11,198 open interest across all expiries and implied volatility of 32% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.